OTTAWA – A new study finds that patients treated for mental illness in Canada are waiting far too long to get drug approval and face inequitable access across the country. The Mood Disorders Society of Canada’s study, System Broken, finds that Canadians who rely on public drug plans are at a particular disadvantage. As we …
OLATHE, Kan. — A new, first-of-its-kind oral pill to treat postpartum depression, which affects 1 in 7 women, comes with a hefty price tag. The U.S. Food and Drug Administration approved Zurzuvae in August, but the company that makes the drug just announced the shocking price this week: $15,900 before insurance. This leaves many doctors …
AstraZeneca is the latest player to enter the weight-loss drug space, a market that some analysts say could reach $100 billion by 2030. On Thursday, the biopharmaceutical company announced it had entered into a licensing agreement with Eccogene for ECC5004 , an oral glucagon-like peptide 1 receptor agonist. This drug, which could fight diseases such …
(The Hill) The Food and Drug Administration (FDA) approved Eli Lilly’s blockbuster diabetes drug for weight loss management on Wednesday, giving patients another tool and opening the door to potentially using much wider. Formal FDA approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely …
The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new drugs that already includes Novo …
A proposed class action lawsuit has been filed in the British Columbia Supreme Court, alleging that the Canadian manufacturer of Ozempic failed to warn potential patients of possible complications. This medication has exploded in popularity since doctors began prescribing it for weight loss. But Tracy Nygaard, 54, was taking Ozempic for its intended purpose, treating …
Minoxidil, a popular hair loss treatment, may be in short supply, experts warn. Minoxidil is the main active ingredient in Rogaine, which is applied to the scalp. Minoxidil has been shown to be most effective when taken orally, but this form has not been approved by the Food and Drug Administration to treat hair loss. …
Health experts in Poland have issued recommendations to the government calling for specific measures to increase drug safety and boost domestic production. Medicine safety encompasses the entire journey of pharmaceutical products, from production facilities to the hands of patients in pharmacies and hospitals. This goes beyond just manufacturing medicines, as Ukasz Szmulski, director of the …
Japan has been plagued by a prolonged shortage of common medications such as cough suppressants, expectorants and antimicrobial agents. According to a survey by a pharmaceutical industry organization, since September, shipments of about 20 percent of all drugs have been either suspended or limited in quantity. Seventy percent of them are generic drugs, which are …
Meta decided that some of its Oversight Board’s objection messages related to intoxicating drugs weren’t worth the effort, so launch the paid ads for ketamine. Therapeutic ketamine only, of course. Although it is still not approved by the FDA. Meta’s oversight board issued four recommendations in August regarding a 2022 sponsored Instagram post advertising the …